← All Conditions ← Cancer Overview

Leukemia

★ CMTO Exam Focus

Leukemia ("white blood") is a group of hematologic cancers characterized by the uncontrolled proliferation of nonfunctioning white blood cells in the bone marrow. These malignant cells crowd out functional red blood cells, healthy white blood cells, and platelets, leading to anemia, bleeding vulnerability, and severe immunocompromise. It is the leading cause of cancer death in children but ten times more common in adults.

Pathophysiology

  • A mutation in bone marrow stem cells causes overproduction of nonfunctioning leukocytes
  • Crowding effect: Malignant cells displace functional erythrocytes, healthy leukocytes, and thrombocytes
  • Classified by speed: acute (immature "blasts") vs. chronic (mature but nonfunctioning cells)
  • Classified by cell line: lymphocytic vs. myelogenous — four combinations (ALL, AML, CLL, CML)
  • Philadelphia chromosome: Found in >90% of CML cases
  • Untreated cases typically result in death from excessive bleeding or overwhelming infection

Signs and Symptoms

Hallmark Indicators

  • Profound fatigue, low stamina, shortness of breath (secondary anemia from displaced RBCs)
  • Easy bruising (ecchymosis) and prolonged bleeding from minor cuts (thrombocytopenia)
  • Petechiae (pinpoint spots) and purpura (purple patches) — direct evidence of dangerously low platelets
  • Recurrent bacterial or viral infections (neutropenia)
  • Deep bone pain and joint tenderness (subperiosteal infiltration and marrow expansion)
  • Painless swelling of lymph nodes and abdominal fullness (splenomegaly/hepatomegaly)
  • Pale skin, gums, and nail beds. Ashy-gray color in dark skin

Red Flags and Rule-Outs

  • Petechiae and purpura: Direct evidence of dangerously low platelet count — modify pressure immediately
  • Fever: Systemic contraindication for massage
  • Splenomegaly (upper left quadrant tenderness): Risk of splenic injury — avoid deep abdominal work
  • Leukostasis: Extremely high blast count (>100,000 cells/uL) makes blood viscous, predisposing to leukoblastic emboli
  • Tumor lysis syndrome: Medical emergency during initial chemotherapy — coordinate with medical team
  • Blasts >20% in bone marrow biopsy: Diagnostic criterion for acute leukemia

MT Considerations

  • Central risks: Clients are extremely vulnerable to bruising (low platelets), bleeding, and infection (neutropenia)
  • Systemic contraindication: Rigorous circulatory massage is contraindicated during acute phases or while febrile
  • Therapeutic role: Gentle, noninvasive touch is valuable for managing pain, anxiety, and sleep disturbances
  • Platelet precaution: If platelets are below 20,000, use pressure no greater than "applying lotion"
  • Tumor lysis syndrome: Massive necrosis of malignant cells during initial chemo can cause life-threatening renal failure
  • Hygiene standard: Severely immunocompromised. Strict IPAC protocols. Postpone if therapist has any active illness
  • Treatment side effects: See chemotherapy and radiation-therapy

CMTO Exam Relevance

  • Classify by speed (acute vs. chronic) and cell line (lymphocytic vs. myelogenous)
  • Petechiae and purpura are direct evidence of dangerously low platelet count
  • Fever is a systemic contraindication
  • Splenomegaly indicates organ involvement and splenic injury risk
  • Philadelphia chromosome is associated with CML
  • Blasts >20% in bone marrow biopsy is diagnostic for acute leukemia

Key Takeaways

  • Leukemia involves overproduction of nonfunctioning WBCs that crowd out healthy blood cells, causing anemia, bleeding, and infection vulnerability
  • Rigorous circulatory massage is systemically contraindicated during acute phases. Gentle touch is appropriate for palliative care
  • If platelets are below 20,000, pressure should be no more than "applying lotion"
  • The therapist must not carry active pathogens into the session due to severe immunocompromise
  • Philadelphia chromosome is found in >90% of CML cases. Tumor lysis syndrome is a medical emergency during initial chemotherapy

Sources

  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.
  • Werner, R. (2016). A massage therapist's guide to pathology (6th ed.). Books of Discovery.
  • Norris, T. L. (2019). Porth's essentials of pathophysiology (5th ed.). Wolters Kluwer.